Latest / Stock Movers / Nvidia Drops on Huang Comeback Report, L3Harris Falls, Helus Pharma Soars
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio, news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg data.
- 0:15Speaker 1: We've got some selling going on out there in the
- 0:19Speaker 1: marketplace today. Let's take a look at some of the
- 0:21Speaker 1: stocks on the move today. We can do that with
- 0:22Speaker 1: Chloe Milley, earnings reporter for Bloomberg News. She joins us
- 0:25Speaker 1: here in studio. Chloe, what are you looking at? Well,
- 0:27Speaker 1: more NVIDIA in case we didn't get enough last week
- 0:30Speaker 1: with some developments over the weekend and this morning as well.
- 0:34Speaker 1: So Trump has just said he wouldn't mind if Jensen
- 0:37Speaker 1: Huang returned as NVIDIA's CEO and that he actually did
- 0:41Speaker 1: not put national security at risk. And so that echoes
- 0:44Speaker 1: a report over the weekend from the FT that some
- 0:48Speaker 1: supporters of Huang are trying to orchestrate his comeback. But
- 0:51Speaker 1: then at the same time, we also have Treasury Secretary
- 0:54Speaker 1: Scott Besant urging NVIDIA to to make a dramatic leadership shakeup,
- 0:58Speaker 1: which would mean finding an external CEO. And there's, of course,
- 1:03Speaker 1: growing pressure on the company to come clean about its
- 1:06Speaker 1: security protocols and, you know, tell us how much it
- 1:09Speaker 1: complied with export controls on AI chips. So, there might
- 1:13Speaker 1: be room for more twists and turns this week. But
- 1:15Speaker 1: in the meantime, all eyes are very much on the
- 1:18Speaker 1: earnings tomorrow. And the interim CEO is going to have
- 1:20Speaker 1: to face a lot of difficult questions from investors.
- 1:25Speaker 2: What else you got for us today?
- 1:26Speaker 1: So I'm looking at L3 Harris, which is an aerospace
- 1:29Speaker 1: and defense contractor that is suddenly coming to the spotlight
- 1:32Speaker 1: because it might be at fault for the travel meltdown
- 1:35Speaker 1: that we had on Friday. So the transportation secretary, Sean Duffy,
- 1:40Speaker 1: said that officials are looking into whether this company was
- 1:43Speaker 1: responsible for that massive shutdown of air traffic control systems
- 1:47Speaker 1: that grounded all flights nationwide last week. L3Harris essentially owns
- 1:53Speaker 1: the equipment used to transmit voice communications and data And
- 1:58Speaker 1: technicians were working on routine maintenance that essentially went wrong
- 2:03Speaker 1: and led to the issue and then the shutdown. Apparently,
- 2:05Speaker 1: that's what has happened. There's not much info yet on
- 2:08Speaker 1: how much blame the company should really be shouldering. And
- 2:12Speaker 1: analysts aren't sure what the impact could be on L3
- 2:16Speaker 1: Harris going forward. It might just be something that really
- 2:19Speaker 1: weighs on sentiment. Or it might be in a worse scenario.
- 2:23Speaker 1: that it's a company that is held financially liable for
- 2:26Speaker 1: the issue. So we'll see what happens there, but it's
- 2:29Speaker 1: down in the market this morning.
- 2:31Speaker 2: It just seems like we need better technology and more
- 2:35Speaker 2: people because that's also been an issue.
- 2:37Speaker 1: Exactly.
- 2:37Speaker 2: So you've got to attract and retain more air traffic controllers.
- 2:41Speaker 2: That's my understanding. It's a combination. of the two. But
- 2:46Speaker 2: it seems like it's fixable, doesn't it? I would hope so.
- 2:49Speaker 1: I mean, geez Louise.
- 2:51Speaker 2: All right, one more here.
- 2:52Speaker 1: One more. Helus Pharma, which is a psychedelic drug company,
- 2:56Speaker 1: it actually had a big jump in pre-market trading and
- 2:59Speaker 1: now a really big drop. And that follows the publication
- 3:03Speaker 1: of some trial data. It said that its experimental treatment
- 3:06Speaker 1: for major depressive disorder had actually met its primary and
- 3:10Speaker 1: key secondary endpoint versus placebo in a study. So it's
- 3:14Speaker 1: an interesting reversal in the shares, given that it does
- 3:17Speaker 1: look like quite solid data. So there's clearly quite a
- 3:20Speaker 1: lot of volatility in that stock and in that broader sector.
- 3:24Speaker 1: But overall, it is a pretty good time to be
- 3:26Speaker 1: doing psychedelic research. Trump did sign an executive order earlier
- 3:30Speaker 1: this year to expedite the approval pathway for those psychedelic drugs.
- 3:34Speaker 1: So that was really seen at the time. That was
- 3:36Speaker 1: back in April as really a turning point. for the industry.
- 3:39Speaker 1: And we might actually start to see some of those
- 3:41Speaker 1: drugs come into market as soon. But yeah, big, big
- 3:44Speaker 1: drop in the shares for Healers Pharma today. All right, Chloe,
- 3:47Speaker 1: thank you so much.
- 3:47Speaker 2: We appreciate that.
- 3:48Speaker 1: Chloe Milley, earnings reporter for Bloomberg News.
- 3:52Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:56Speaker 2: us throughout the day for the latest roundup of companies
- 3:58Speaker 2: making news on Wall Street. And for the latest market-moving headlines,
- 4:03Speaker 2: listen to Bloomberg Radio live. Catch us on YouTube, Bloomberg.com,
- 4:07Speaker 2: and on Apple CarPlay and Android Auto with the Bloomberg
- 4:10Speaker 2: Business app.